Patent · US Active

Compounds having CRTH2 antagonist activity

US8168673B2 · kind B2 · utility

7Cited by
10References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 22, 2009
Grant dateMay 1, 2012
Priority date—
Expiry dateNov 5, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of general formula (I)

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.